Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-05-28 16:23 Tx date 2024-05-27 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$566.70
+6,667 vol $0.085 each |
6,667 | |
Filed 2024-05-28 16:23 Tx date 2023-05-12 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-05-28 16:21 Tx date 2024-05-27 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-6,667 vol |
213,333 | |
Filed 2023-11-30 17:14 Tx date 2023-11-28 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+200,000 vol |
220,000 | |
Filed 2023-05-26 14:03 Tx date 2023-05-25 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+20,000 vol |
20,000 | |
Filed 2023-05-26 14:02 Tx date 2023-05-12 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-05-26 14:00 Tx date 2023-05-24 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+200,000 vol |
200,000 | |
Filed 2023-05-26 13:58 Tx date 2023-05-12 |
$WLLW
Willow Biosciences Inc. |
Asadorian, Raffi
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|